Cinctive Capital Management LP

Position in ANNX — Annexon, Inc.

CIK 1787258 New York, NY

Position in ANNX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,231,921

-$256,344 QoQ

Shares Held

215,748

-19.7% QoQ

Ownership

0.106%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#74

of 216 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cinctive Capital Management LP holds $200,361,017 across 44 Biotechnology names. ANNX ranks #31 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	350,165	$46,477,400
2	INSM	INSMED Inc	161,996	$17,272,013
3	VRTX	Vertex Pharmaceuticals Inc / Ma	26,712	$13,268,651
4	CYTK	Cytokinetics Inc	137,838	$11,742,419
5	ROIV	Roivant Sciences Ltd.	226,140	$8,003,094
6	NTHI	Neonc Technologies Holdings, Inc.	1,607,464	$7,281,811
7	ERAS	Erasca, Inc.	391,642	$7,174,881
8	KRYS	Krystal Biotech, Inc.	16,367	$6,083,122

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,231,921	215,748	-19.7%	Shares	Sole	2026-08-14
2026-03-31	$1,488,265	268,640	-25.2%	Shares	Sole	2026-05-15
2025-12-31	$1,802,109	358,986	+448.4%	Shares	Sole	2026-02-17
2025-09-30	$199,671	65,466	-51.7%	Shares	Sole	2025-11-14
2025-06-30	$325,118	135,466	0.0%	Shares	Sole	2025-08-14
2025-03-31	$261,449	135,466	0.0%	Shares	Sole	2025-05-15
2024-12-31	$694,940	135,466	-27.5%	Shares	Sole	2025-02-12
2024-09-30	$1,106,021	186,828	-14.3%	Shares	Sole	2024-11-14
2024-06-30	$1,068,641	218,090	+392.3%	Shares	Sole	2024-08-14
2024-03-31	$317,631	44,300	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.